Sign in to continue:

Tuesday, March 10th, 2026

Shandong Chenming Paper Holdings Announces Board Meeting to Approve 2025 Annual Results and Profit Distribution Plan

Shandong Chenming Paper Holdings Limited Announces Board Meeting for 2025 Annual Results and Profit Distribution Plan

Shandong Chenming Paper Holdings Limited Announces Key Board Meeting on 2025 Annual Results

Key Highlights for Investors

  • Scheduled Board Meeting: The Board of Directors of Shandong Chenming Paper Holdings Limited has announced that a critical board meeting will be held on Monday, 30 March 2026.
  • Annual Results Approval: The main purpose of this meeting is to consider and approve the annual results for the year ended 31 December 2025 for both the Company and its subsidiaries. The announcement and publication of these results will follow the board meeting.
  • Profit Distribution Plan: The Board will also deliberate on the proposed profit distribution plan (if any), which may include dividend proposals or other forms of shareholder returns.
  • Official Communication: The announcement was made by Chairman Jiang Yanshan on behalf of the Board, underscoring the importance of this upcoming event.
  • Board Composition: The current board comprises a mix of executive, non-executive, and independent non-executive directors, reflecting a diversified governance structure.

Implications for Shareholders and Potential Market Sensitivity

  • Price Sensitive Event: The annual results and any associated profit distribution plan—including possible dividends—are highly significant for shareholders. Approval of robust financial results or an attractive dividend could potentially move the share price.
  • Actionable Date: Investors should closely monitor the results announcement following the Board meeting on 30 March 2026, as this will provide crucial insight into the Company’s performance and future payout policy.
  • Transparency and Governance: The detailed disclosure of board composition provides confidence in the Company’s governance practices, which is important for investor trust.

Detailed Board Composition

  • Executive Directors: Mr. Jiang Yanshan (Chairman), Mr. Li Weixian, Mr. Liu Peiji, Mr. Meng Feng, Ms. Zhu Yanli
  • Non-Executive Directors: Mr. Song Yuchen, Ms. Wang Ying
  • Independent Non-Executive Directors: Mr. Zhang Zhiyuan, Mr. Luo Xinhua, Mr. Wan Gang, Mr. Kong Pengzhi

What Should Shareholders Watch For?

  1. The publication of the 2025 annual results, which will reflect the Company’s operational and financial performance.
  2. Any proposed profit distribution plan, as this will directly impact potential returns to shareholders.
  3. Board’s commentary on future outlook and strategic direction, which often accompanies annual results releases.

Disclaimer: The above article summarizes key developments based on the official announcement by Shandong Chenming Paper Holdings Limited. The information provided does not constitute investment advice. Investors are advised to conduct their own due diligence and consult professional advisors before making investment decisions. Market reactions may vary, and past performance is not indicative of future results.


View CHENMING PAPER Historical chart here



Zhenro Services Group Limited Announces Board Meeting to Approve 2025 Annual Results and Dividend Recommendation 1

Zhenro Services Group Limited Announces Date of Board Meeting for 2025 Audited Results Zhenro Services Group Limited Sets Board Meeting to Approve 2025 Audited Results and Consider Final Dividend Key Points: Board Meeting Scheduled:...

Fortior Technology (Shenzhen) Issues Positive Profit Alert for 2025 with Strong Revenue and Asset Growth

Fortior Technology (Shenzhen) Co., Ltd. Issues Positive Profit Alert for 2025 Fortior Technology (Shenzhen) Co., Ltd. Issues Positive Profit Alert for 2025 Key Highlights from the 2025 Profit Alert Announcement Significant Increase in Operating...

Shanghai Junshi Biosciences Announces 2025 Preliminary Results: Revenue Growth and Narrowed Net Losses Driven by Toripalimab Sales Expansion 1

Shanghai Junshi Biosciences 2025 Preliminary Results: Key Highlights for Investors Shanghai Junshi Biosciences Announces 2025 Preliminary Results: Strong Revenue Growth and Narrowing Losses Shanghai Junshi Biosciences Co., Ltd. (Stock code: 1877) has released its...

   Ad